Diligence memo · auto-generated · as of July 3, 2026

Patient Home Monitoring Corp.

Patient Home Monitoring Corp. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Patient Home Monitoring Corp. operates in Healthtech, based in WILDER.

Sub-sector tags: healthtech.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Patient Home Monitoring Corp. has raised $73M in disclosed capital across 23 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $40M on 2015-07-10.

Most recent recorded round closed around 2020-06-29.

Filings read as a recurring offering program rather than a clean venture-stage ladder — interpret stage labels and step-ups with that in mind.

Valuation (modeled)modeled

Provath models Patient Home Monitoring Corp. at approximately $117M (range $11M–$450M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.26× the median modeled value of Series B Healthtech companies in 2019–2021 (56 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 4 months.

Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 16.5× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 94% of Healthtech peers (2138 compared).

Modeled value ranks above 80% of those peers.

Closest niche peers: Solera Health, Inc., Icebreaker Health, Inc., Buoy Health, Inc., Stroma Medical Corp, HealthJoy, Inc..

Peoplefiled

22 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.

Recurring-offering pattern: stage-based valuation has lower applicability.